Zhou S-Y, Gillilland M, Wu X, Leelasinjaroen P, Zhang G, Zhou H, et al
Practical Considerations for Prescribers When planning treatment strategies in 2026, its important to address the side effects of metformin, its affordability, and how it compares to newer medications in patient-specific contexts
Blood sugar can matter for some people GLP1 medications alone are unlikely to cause dangerously low blood sugar, but risk increases when they are combined with insulin or sulfonylureas
Epidemiological Evidence of Post-COVID IBS At 12-month follow-up, patients with COVID-19 had significantly higher IBS rates compared with controls (3.2% vs 0.5%, p=0.045). Post-COVID-19 IBS Integrative Review Authors , Authors of a peer-reviewed integrative review on post-COVID-19 IBS Mounting evidence points to a significant relationship between SARS-CoV-2 infection and subsequent development of irritable bowel syndrome, with expanding research now quantifying this association across diverse patient populations
Structured intake, verified pharmacy integration, async communication, and cash-pay billing are the four requirements